T. Dixon Re: Growth and Expansion
Post by TimGDixon » Tue Oct 19, 2021 7:58 am
Yes the stem cell market is growing and will continue to do so. We haven't entered that market yet but we are preparing to and we're not just going to take a slice of the pie we are going to increase the pie size. Approved mesenchymal stem cells that are intravenously administered bring in between $100,000 - $200,000 per patient which would include the fees charged by the provider. Thats the target not EUA, RTT, eIND, those are acts of compassion.